🇺🇸 FDA
Patent

US 11613735

Methods for reprograming non-hepatocyte cells into hepatocyte cells

granted A61KA61K35/407A61P

Quick answer

US patent 11613735 (Methods for reprograming non-hepatocyte cells into hepatocyte cells) held by BeiHao Stem Cell and Regenerative Medicine Translational Research Institute expires Mon Mar 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
BeiHao Stem Cell and Regenerative Medicine Translational Research Institute
Grant date
Tue Mar 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K35/407, A61P, A61P1/16